Other miR-200c targets identified by RNA sequencing included Arhgap6, Dmd, Slc14a1, and Vldlr. Dmd and Vldlr have previously been identified as regulators of breast cancer where their expression has been associated with paclitaxel or bevacizumab response [93, 94] and migration/metastasis [95]. The gene discussed is DMD; the disease is breast cancer.